MDLN
MDLN
MDLN
Medline Inc. is drawing attention following the announcement: Kaplan Fox Encourages Medline Inc. (MDLN) Investors to Contact the Firm Regarding a Securities Investigation. The company holds a market capitalization of approximately 27.24 billion and generated full-year revenue of 28.432 billion. In addition, its valuation reflects a PE ratio of 37.45, alongside a TTM EPS of 0.81 and a free cash flow yield of 7.44%.
Based on newsfilecorp.comMDLN Securities Announcement: Medline Investors with Losses may have Rights in an Ongoing Securities Fraud Investigation – Contact BFA Law
Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN
$MDLN Investors: A Securities Fraud Investigation is Pending on behalf of Medline Investors that Lost Money after 13% Stock Drop – Contact BFA Law
Medline Inc. Investigation Continues: Investors May Contact Kirby McInerney LLP, a Securities Fraud Law Firm, If You Lost Money On Your MDLN Investments
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN
Revenue & Net Income (5Y)
EPS & Growth (5Y)
Free Cash Flow (5Y)
Capital Returns
Operating & Net Margin (5Y)
CapEx vs. Free Cash Flow (5Y)
Capital Allocation (5Y)
R&D and SG&A Intensity (5Y)
EBITDA (5Y)
Cost of Revenue (5Y)
Market Cap (5Y)
Ask Blinx with professional market data, charts beside chat, and your portfolio context.
Default quotes are Lang & Schwarz. NASDAQ is the delayed listing price. Charts stay daily. Not investment advice.